Pelthos Therapeutics Inc.
AMEX:PTHSBiotechnology
-$0.37 today
- Market cap
- $63.32M
- Beta
- 3.13
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$15.58
Volume 0.01M
Average 0.04M
PTHS Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Pelthos Therapeutics Inc.AMEX: PTHS
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) remains negative
Q1 FY2026 property, plant & equipment (net) was $12.46M, compared with $0 a year earlier.
Context
- Property, plant & equipment (net) amounted to 8.6% of total assets at the end of Q1 FY2026, up 8.6 pp from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 12.84M USD
- Year-over-year change
- —
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.84M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Property, Plant & Equipment (Net) vs competitors
How PTHS compares with its peers on the latest reported figures
- PTHS's Mar 2026 property, plant & equipment (net) of $12.46M is the highest of the 4 companies compared; the peer median is $938K.
- Property, plant & equipment (net) amounts to 8.6% of total assets for PTHS, versus a peer median of 7.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $12.46M | — | — | 8.6% | |
| Mar 2026 | $2.95M | +50.1% | -4.6% | 9.6% | |
| Dec 2025 | $938K | -18.6% | -60.2% | 0.0% | |
| Mar 2026 | $850.13K | — | — | 7.8% | |
| Peer median (excluding PTHS) | $938K | +15.7% | -32.4% | 7.8% | |
Competitors are the stored peer set for PTHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Pelthos Therapeutics Inc.
AMEX:PTHS
Intrinsic Alpha fair value
Locked
Current Price
$16.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.